Scotiabank analyst Louise Chen raised the firm’s price target on Gilead (GILD) to $177 from $140 and keeps an Outperform rating on the shares. The firm notes Gilead’s execution continues to exceed expectations, the analyst tells investors.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GILD:
- Gilead price target raised to $170 from $140 at Needham
- Gilead price target raised to $171 from $150 at Morgan Stanley
- Invesco QQQ Trust ETF (QQQ) Daily Update, 2/11/2026
- Gilead price target raised to $152 from $145 at Truist
- Underappreciated Earnings Power: Why Strong HIV Momentum and Margin Expansion Support a Buy on Gilead